229 related articles for article (PubMed ID: 9126996)
1. Surfactant protein A-deficient mice are susceptible to group B streptococcal infection.
LeVine AM; Bruno MD; Huelsman KM; Ross GF; Whitsett JA; Korfhagen TR
J Immunol; 1997 May; 158(9):4336-40. PubMed ID: 9126996
[TBL] [Abstract][Full Text] [Related]
2. Surfactant protein-A-deficient mice are susceptible to Pseudomonas aeruginosa infection.
LeVine AM; Kurak KE; Bruno MD; Stark JM; Whitsett JA; Korfhagen TR
Am J Respir Cell Mol Biol; 1998 Oct; 19(4):700-8. PubMed ID: 9761768
[TBL] [Abstract][Full Text] [Related]
3. Surfactant protein-A binds group B streptococcus enhancing phagocytosis and clearance from lungs of surfactant protein-A-deficient mice.
LeVine AM; Kurak KE; Wright JR; Watford WT; Bruno MD; Ross GF; Whitsett JA; Korfhagen TR
Am J Respir Cell Mol Biol; 1999 Feb; 20(2):279-86. PubMed ID: 9922219
[TBL] [Abstract][Full Text] [Related]
4. Immunosuppressed surfactant protein A-deficient mice have increased susceptibility to Pneumocystis carinii infection.
Linke MJ; Harris CE; Korfhagen TR; McCormack FX; Ashbaugh AD; Steele P; Whitsett JA; Walzer PD
J Infect Dis; 2001 Mar; 183(6):943-52. PubMed ID: 11237812
[TBL] [Abstract][Full Text] [Related]
5. Pneumocystis carinii pneumonia alters expression and distribution of lung collectins SP-A and SP-D.
Atochina EN; Beck JM; Scanlon ST; Preston AM; Beers MF
J Lab Clin Med; 2001 Jun; 137(6):429-39. PubMed ID: 11385364
[TBL] [Abstract][Full Text] [Related]
6. Distinct effects of surfactant protein A or D deficiency during bacterial infection on the lung.
LeVine AM; Whitsett JA; Gwozdz JA; Richardson TR; Fisher JH; Burhans MS; Korfhagen TR
J Immunol; 2000 Oct; 165(7):3934-40. PubMed ID: 11034401
[TBL] [Abstract][Full Text] [Related]
7. Pulmonary surfactant protein A mediates enhanced phagocytosis of Mycobacterium tuberculosis by a direct interaction with human macrophages.
Gaynor CD; McCormack FX; Voelker DR; McGowan SE; Schlesinger LS
J Immunol; 1995 Dec; 155(11):5343-51. PubMed ID: 7594549
[TBL] [Abstract][Full Text] [Related]
8. Localization and functions of SP-A and SP-D at mucosal surfaces.
van Rozendaal BA; van Golde LM; Haagsman HP
Pediatr Pathol Mol Med; 2001; 20(4):319-39. PubMed ID: 11486736
[TBL] [Abstract][Full Text] [Related]
9. Lung function and bacterial proliferation in experimental neonatal pneumonia in ventilated rabbits exposed to monoclonal antibody to surfactant protein A.
Herting E; Strayer DS; Jarstrand C; Sun B; Robertson B
Lung; 1998; 176(2):123-31. PubMed ID: 9500297
[TBL] [Abstract][Full Text] [Related]
10. Pulmonary surfactant protein A modulates the cellular response to smooth and rough lipopolysaccharides by interaction with CD14.
Sano H; Sohma H; Muta T; Nomura S; Voelker DR; Kuroki Y
J Immunol; 1999 Jul; 163(1):387-95. PubMed ID: 10384140
[TBL] [Abstract][Full Text] [Related]
11. Surfactant protein A down-regulates proinflammatory cytokine production evoked by Candida albicans in human alveolar macrophages and monocytes.
Rosseau S; Hammerl P; Maus U; Günther A; Seeger W; Grimminger F; Lohmeyer J
J Immunol; 1999 Oct; 163(8):4495-502. PubMed ID: 10510392
[TBL] [Abstract][Full Text] [Related]
12. Alveolar macrophages, surfactant lipids, and surfactant protein B regulate the induction of immune responses via the airways.
van Iwaarden JF; Claassen E; Jeurissen SH; Haagsman HP; Kraal G
Am J Respir Cell Mol Biol; 2001 Apr; 24(4):452-8. PubMed ID: 11306439
[TBL] [Abstract][Full Text] [Related]
13. Delayed clearance of pneumocystis carinii infection, increased inflammation, and altered nitric oxide metabolism in lungs of surfactant protein-D knockout mice.
Atochina EN; Gow AJ; Beck JM; Haczku A; Inch A; Kadire H; Tomer Y; Davis C; Preston AM; Poulain F; Hawgood S; Beers MF
J Infect Dis; 2004 Apr; 189(8):1528-39. PubMed ID: 15073692
[TBL] [Abstract][Full Text] [Related]
14. Alteration of surfactant proteins A and D in bronchoalveolar lavage fluid of Pneumocystis carinii pneumonia.
Qu J; He L; Rong Z; Pan J; Chen X; Morrison DC; Li X
Chin Med J (Engl); 2001 Nov; 114(11):1143-6. PubMed ID: 11729507
[TBL] [Abstract][Full Text] [Related]
15. Surfactant protein A (SP-A)-mediated bacterial clearance: SP-A and cystic fibrosis.
Korfhagen TR
Am J Respir Cell Mol Biol; 2001 Dec; 25(6):668-72. PubMed ID: 11726390
[No Abstract] [Full Text] [Related]
16. Design-based stereological analysis of the lung parenchymal architecture and alveolar type II cells in surfactant protein A and D double deficient mice.
Jung A; Allen L; Nyengaard JR; Gundersen HJ; Richter J; Hawgood S; Ochs M
Anat Rec A Discov Mol Cell Evol Biol; 2005 Oct; 286(2):885-90. PubMed ID: 16086431
[TBL] [Abstract][Full Text] [Related]
17. SP-A enhances viral clearance and inhibits inflammation after pulmonary adenoviral infection.
Harrod KS; Trapnell BC; Otake K; Korfhagen TR; Whitsett JA
Am J Physiol; 1999 Sep; 277(3):L580-8. PubMed ID: 10484466
[TBL] [Abstract][Full Text] [Related]
18. Human surfactant protein a suppresses T cell-dependent inflammation and attenuates the manifestations of idiopathic pneumonia syndrome in mice.
Yang S; Milla C; Panoskaltsis-Mortari A; Ingbar DH; Blazar BR; Haddad IY
Am J Respir Cell Mol Biol; 2001 May; 24(5):527-36. PubMed ID: 11350821
[TBL] [Abstract][Full Text] [Related]
19. Surfactant protein A decreases lung injury and mortality after murine marrow transplantation.
Yang S; Milla C; Panoskaltsis-Mortari A; Hawgood S; Blazar BR; Haddad IY
Am J Respir Cell Mol Biol; 2002 Sep; 27(3):297-305. PubMed ID: 12204891
[TBL] [Abstract][Full Text] [Related]
20. Surfactant proteins A and D protect mice against pulmonary hypersensitivity induced by Aspergillus fumigatus antigens and allergens.
Madan T; Kishore U; Singh M; Strong P; Clark H; Hussain EM; Reid KB; Sarma PU
J Clin Invest; 2001 Feb; 107(4):467-75. PubMed ID: 11181646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
